Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The impact of dissolution in the lower intestine on the absorption of high dose low solubility drugs
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-073-Monday
- By: VERTZONI, Maria (National and Kapodistrian University of Athens, Pharmacy, Athens, Greece)
- Co-author(s): Danai Georgaka: Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
James Butler: Product Development, GlaxoSmithKline, Ware, United Kingdom
Filippos Kesisoglou: Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Kenilworth, United States
Christos Reppas: Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
Maria Vertzoni: Pharmacy, National and Kapodistrian University of Athens, Athens, Greece - Abstract:
Backgrounds
This work was performed within the OrBiTo project funded by the IMI Joint Undertaking under Grant Agreement No 115369.
Aims
Τo evaluate the impact of dissolution in the lower intestine on the absorption of three model, high dose, low solubility drugs, i.e. micronized aprepitant, SB705498 [Immediate release tablets (25mg/tab) and Capsules
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023